Abstract:Ethnopharmacological relevance: Inflammatory bowel disease (IBD) is a globally increasing disease. Despite continuous efforts, the clinical application of treatment drugs has not achieved satisfactory success and faces limitations such as adverse drug reactions. Numerous investigations have found that the pathogenesis of IBD is connected with disturbances in bile acid circulation and metabolism. Traditional Chinese medicine targeting bile acids (BAs) has shown significant therapeutic effects and advantages in treating inflammatory bowel disease. Aim of this review: IThis article reviews the role of bile acids and their receptors in IBD, as well as research progress on IBD therapeutic drugs based on bile acids. It explores bile acid metabolism and its interaction with the intestinal microbiota, summarizes clinical drugs for treating IBD including single herbal medicine, traditional herbal prescriptions, and analyzes the mechanisms of action in treating IBD. Materials and methods: IThe electronic databases such as PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) have been utilized to retrieve relevant literature up to January 2024, using keywords "bile acid", "bile acid receptor", "inflammatory bowel disease", "intestinal microbiota" and "targeted drugs". Results: IImbalance in bile acid levels can lead to intestinal inflammation, while IBD can disrupt the balance of microbes, result in alterations in the bile acid pool's composition and amount. This change can damage of intestinal mucosa healing ability. Bile acids are vital for keeping the gut barrier function intact, regulating gene expression, managing metabolic equilibrium, and influencing the properties and roles of the gut's microbial community. Consequently, focusing on bile acids could offer a potential treatment strategy for IBD. Conclusion: IIBD can induce intestinal homeostasis imbalance and changes in BA pool, leading to fluctuations in levels of relevant metabolic enzymes, transporters, and nuclear receptors. Therefore, by regulating the balance of BA and key signaling molecules of bile acids, we can treat IBD. Traditional Chinese medicine has great potential and promising prospects in treating IBD. We should focus on the characteristics and advantages of Chinese medicine, promote the development and clinical application of innovative Chinese medicine, and ultimately make Chinese medicine targeting bile acids the mainstream treatment for IBD.

The influence of bile acid, microbiota and their interaction on inflammatory bowel disease and the related progress in clinical application

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside

Interactive Relationships Between Intestinal Flora and Bile Acids.

Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis

Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

Gut microbiota and inflammatory bowel disease: The current status and perspectives

Emerging roles of bile acids in mucosal immunity and inflammation

Role of bile acids in liver diseases mediated by the gut microbiome

Probiotics Interact With Lipids Metabolism and Affect Gut Health

Bile acids as inflammatory mediators and modulators of intestinal permeability

The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy

Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis

Research progress on relationship between bile acids and intestinal mucosal mechanical barrier function

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease